Researches

South Egypt Cancer Institute

Assiut University

# Title Department Research Member Research Year
581 Long-Term Evaluation of Imatinib´s Effect on Bone Marrow Fibrosis in Patients with Chronic Myeloid Leukemia
 		Department of Medical Oncology Dr. Adel Gomaa Mohamed Gabr 2019
582 Long-Term Evaluation of Imatinib´s Effect on Bone Marrow Fibrosis in Patients with Chronic Myeloid Leukemia
 		Department of Clinical Pathology Dr. Asmaa Mohamed Zahran Omar 2019
583 Complication versus Radicality in Papillary Thyroid Cancer Surgery: How to Keep the Balance? Department of Surgical Oncology Dr. Ali Zedan Tohamy mohammed 2019
584 Circulating hematopoietic stem cells, endothelial
progenitor cells and cancer stem cells in
hepatocellular carcinoma patients: contribution to
diagnosis and prognosis 		Department of Medical Oncology Dr. Ahmed Refaat Abdel Zaher Mubarak 2019
585 Assessment of the Use of 8 color Flowcytometry in the Diagnosis of Acute Leukemia Department of Clinical Pathology Dr. Noha gaber sayed 2019
586 Circulating hematopoietic stem cells, endothelial
progenitor cells and cancer stem cells in
hepatocellular carcinoma patients: contribution to
diagnosis and prognosis 		Department of Radiotherapy and Nuclear medicine Dr. Mona Mahmoud Sayed 2019
587 Prognostic Value of c-Myc Immunohistochemical Expression in Muscle Invasive Urothelial Carcinoma of the Urinary Bladder: A Retrospective Study
 		Department of Pathology Dr. Tarek Mohamed Abdel Moneim Mohamed Elsaba Ahmed 2019
588 The Prognostic Implication of CD49d Expression by Flow Cytometry and Trisomy 12 Detection by Fluorescent in situ Hybridization in Chronic Lymphocytic Leukemia Department of Medical Oncology Dr. Mayada Fawzy Sedik Farghaly 2019
589 Long-Term Evaluation of Imatinib´s Effect on Bone
Marrow Fibrosis in Patients with Chronic Myeloid
Leukemia 		Department of Clinical Pathology Prof. Hosny Badrawy Hamed Omran 2019
590 Correlation Between the Overall Disease Prognosis and The Percentage of Both (Trisomy 12 and CD49d Expression) in Patients with Chronic Lymphocytic Leukemia (CLL)
 		Department of Clinical Pathology Prof. Eman Massad Zaki El-Hefny 2019